Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. NB378451

TOM1L1 Antibody (TOM1L1/4690), DyLight 405, Novus Biologicals™
SDP

Catalog No. NB378451 Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
100 μg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NB378451 100 μg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NB378451 Supplier Novus Biologicals Supplier No. NBP308878V
Add to Cart
Add to Cart

Description

Mouse Monoclonal Antibody

TOM1L1 Monoclonal antibody specifically detects TOM1L1 in Human samples. It is validated for Immunohistochemistry (Paraffin)

Specifications

Antigen TOM1L1
Applications Immunohistochemistry (Paraffin)
Classification Monoclonal
Clone TOM1L1/4690
Conjugate DyLight 405
Formulation 50mM Sodium Borate
Gene Alias OK/KNS-CL.3, Src-activating and signaling molecule protein, SRCASMSrc activating and signaling molecule, target of myb 1-like 1, target of myb1 (chicken) homolog-like 1, target of myb1 (chicken)-like 1, target of myb1-like 1, Target of Myb-like protein 1, TOM1-like protein 1
Host Species Mouse
Immunogen Recombinant full-length human TOM1L1 protein (Uniprot: O75674)
Purification Method Protein A or G purified
Quantity 100 μg
Regulatory Status RUO
Primary or Secondary Primary
Gene ID (Entrez) 10040
Target Species Human
Content And Storage Store at 4°C in the dark.
Form Purified
Isotype IgG
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.